![conference banner](/images/conference-banner.jpeg)
Abstract
Hypovolemic shock (HS), a clinical condition of insufficient blood perfusion and oxygenation in body tissues, is associated with immense morbidity and mortality. Treatment approaches include fluid replacement and surgical repair of reversible causes of hemorrhage; however, they cause irreversible blood perfusion loss, systemic inflammation, multiple organ failure, and death. Centhaquin citrate (CC) is an innovative centrally acting cardiovascular active agent that is initially intended as an antihypertensive drug. However, due to its positive ionotropic effect, Centhaquin citrate is being tested clinically as a resuscitative agent for the management of hypovolemic shock It acts at the α2B-adrenergic receptor to produce venous constriction followed by an increase in venous return to the heart. These actions are assumed to be capable of resuscitative activity observed by centhaquin citrate, through an increase in cardiac output and tissue perfusion. Pharmacokinetics investigations in animals and humans have shown that centhaquin citrate is well tolerated and has insignificant side effects. Therefore, centhaquin citrate seems to be a promising entity and gaining the interest of researchers to develop it as a resuscitative agent in HS. The review gives insight into the development of centhaquin citrate as a resuscitative agent and provides insight into the associated mechanism of action and molecular signalling to foster future research on CC for its clinical use in HS.
Keywords: Centhaquin, hemorrhagic shock, cardiac output, blood lactate, resuscitation agent, HIF pathway.
[http://dx.doi.org/10.1007/s40265-021-01547-5] [PMID: 34061314]
[http://dx.doi.org/10.1016/j.intimp.2022.108902] [PMID: 35729835]
[http://dx.doi.org/10.1016/j.suc.2012.08.006] [PMID: 23153876]
[http://dx.doi.org/10.1016/S0749-0704(18)30195-7] [PMID: 8490762]
[http://dx.doi.org/10.1016/j.jss.2012.08.042] [PMID: 22964270]
[http://dx.doi.org/10.1111/jphp.12554] [PMID: 27109141]
[http://dx.doi.org/10.1016/j.jss.2015.06.056] [PMID: 26216751]
[http://dx.doi.org/10.1002/chin.199009348]
[http://dx.doi.org/10.1107/S0108270190007211]
[http://dx.doi.org/10.1016/1043-6618(90)90729-W]
[http://dx.doi.org/10.1002/ddr.430230404]
[http://dx.doi.org/10.1055/s-0032-1329985] [PMID: 23154885]
[http://dx.doi.org/10.33549/physiolres.933856] [PMID: 29947540]
[http://dx.doi.org/10.1111/jphp.13336] [PMID: 33460133]
[http://dx.doi.org/10.1097/01.ccm.0000439677.20938.e9]
[http://dx.doi.org/10.1007/s12325-021-01760-4] [PMID: 33970455]
[http://dx.doi.org/10.1016/j.jss.2012.02.005] [PMID: 22487389]
[http://dx.doi.org/10.1161/01.CIR.0000069826.36125.B4]
[PMID: 29593847]
[http://dx.doi.org/10.4103/0974-2700.82210] [PMID: 21769210]
[http://dx.doi.org/10.1038/348730a0] [PMID: 2175396]
[http://dx.doi.org/10.1073/pnas.86.10.3915] [PMID: 2542956]
[http://dx.doi.org/10.1016/0014-2999(93)90564-X] [PMID: 8440307]
[http://dx.doi.org/10.2174/1874192401004010302] [PMID: 21339899]
[http://dx.doi.org/10.1152/ajpregu.00397.2010] [PMID: 21368267]
[http://dx.doi.org/10.1152/ajpregu.1990.259.4.R663] [PMID: 2145776]
[http://dx.doi.org/10.1007/s00005-014-0310-1] [PMID: 25288367]
[PMID: 7490515]
[http://dx.doi.org/10.1016/j.ccr.2006.08.026] [PMID: 17097563]
[http://dx.doi.org/10.1002/1873-3468.12956] [PMID: 29281123]
[http://dx.doi.org/10.3389/fphar.2021.616253] [PMID: 34012389]
[http://dx.doi.org/10.1016/j.bbadis.2016.11.005] [PMID: 27825853]
[http://dx.doi.org/10.1210/en.2005-0250]
[http://dx.doi.org/10.2174/0929867321666131228205146] [PMID: 24372209]
[http://dx.doi.org/10.1016/j.neuroscience.2022.03.016] [PMID: 35314251]
[http://dx.doi.org/10.1016/j.intimp.2022.108951] [PMID: 35717837]
[http://dx.doi.org/10.1515/jbcpp-2020-0330] [PMID: 33548170]
[http://dx.doi.org/10.1016/j.retram.2020.05.002] [PMID: 32620467]
[http://dx.doi.org/10.5958/0974-360X.2020.00699.X]
[http://dx.doi.org/10.1007/s11064-022-03646-5] [PMID: 35689787]